utilized the fat‐mass and obesity‐associated protein (FTO) to epigenetically inhibit APOE expression in PTC, leading to the inhibition of glycolytic metabolism via the IL‐T/JAK/STAT3 signalling pathway and subsequent suppression of tumour growth. The gene discussed is FTO; the disease is neoplasm.